Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the safety and efficacy of ATHENA CAR-T in subjects with systemic lupus erythematosus; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• ATHENA CAR-T

Snippet

Sponsor: EdiGene Inc. | Conditions: Lupus Erythematosus, Systemic | Phase 1 | Status: NOT_YET_RECRUITING